Oxford Biomedica PLC
22 May 2006
Oxford BioMedica plc (the 'Company')
Holdings in Company
The Company was notified on 22 May 2006 by M&G Investment that following recent
purchases, at 18 May 2006 Prudential plc and certain of its subsidiary companies
had a notifiable interest in 20,541,106 of the Company's ordinary shares of 1p each
('Ordinary Shares'), representing 4.11 per cent. of the issued ordinary share capital.
The Prudential Assurance Company Limited
Registered holder Shares %
PRUCLT HSBC GIS NOM(UK) PAC AC 19,700,368 3.94
PRUCLT HSBC GIS NOM(UK) PPL AC 840,738 0.17
Total 20,541,106 4.11
In the Company's annual report and accounts, dated 11 May 2006, a total holding
of 39,825,426 Ordinary Shares, representing 7.97 per cent. of the Company's
total issued share capital was disclosed for M&G Investment. Following the
recent purchases, this holding now totals a beneficial interest of 41,815,637
Ordinary Shares, representing 8.37 per cent. of the total issued ordinary share
capital.
22 May 2006
Andrew Wood
Chief Financial Officer
Tel. 01865 783000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.